Skip to main content
Premium Trial:

Request an Annual Quote

Surely Comparing Synthetic Bio to GMO Is Not the Way to Win Over the European Public

This week the Engineering Life conference kicks off in London, and this article from The Observer describes synthetic biology, which it calls "one of the most audacious, and controversial, scientific ideas of the 21st century." Scientists in the article say the field will have to be "properly monitored," and they point out that genetically modified foods are based on similar concepts.

Speaking of GMOs, this New York Times article says the argument that might finally win over the masses is cost. "Soaring food prices and global grain shortages are bringing new pressures on governments, food companies and consumers to relax their longstanding resistance to genetically engineered crops," the story says.

 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.